Fortrea Holdings (FTRE) Divestments (2024 - 2025)
Fortrea Holdings' (FTRE) quarterly Divestments came in at $20.6 million in Q3 2025, up 339.53% YoY from $4.7 million in Q3 2024, and up 8.42% on a QoQ basis from $19.0 million in Q1 2025.
Powered by 
Analysis
Fortrea Holdings (FTRE) Divestments (2024 - 2025) Analysis & Trends
Fortrea Holdings (FTRE) has 2 years of Divestments data on file, last reported at $20.6 million in Q3 2025.
- Quarterly Divestments rose 339.53% year-over-year to $20.6 million in Q3 2025, while the trailing twelve-month figure through Jun 2026 was $20.6 million (up 98.08% YoY) and the FY2025 annual result came in at $39.6 million, down 85.68% from the prior year.
- Divestments climbed to $20.6 million in Q3 2025, from $19.0 million in the prior quarter.
- In the past five years, Divestments ranged from a high of $285.2 million in Q2 2024 to a low of -$8.6 million in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | -13.21 Mn |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | - |
| 10 | Fortrea Holdings | 1.71 Bn | 1.54 Bn | 139.20 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 20.60 Mn |
| Mar 31, 2025 | 19.00 Mn |
| Sep 30, 2024 | -8.60 Mn |
| Jun 30, 2024 | 285.20 Mn |